David Eng

FDA investigator

Appears on 5 documents from 2015 to 2016, mostly at sites in California. Most often cites design and construction features (21 CFR 211.42).

5
Documents on file
6.2
Observations per 483
2015
First seen
2016
Most recent

What they cite most

From 31 observations

Activity by year

2015: 3, 2016: 2

Where

California 3 · Nevada 2

Is David Eng coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Well Care Discount Pharmacy LLC, dba Well Care Compounding PharmacyMay 12, 2016 · Las Vegas, Nevada
483 Meditech Laboratories, Inc.Mar 18, 2016 · Las Vegas, Nevada
483 Acorn NMR IncDec 11, 2015 · Livermore, California
483 Gcncntcch IncAug 28, 2015 · Vacaville, California
483 Alexza Pharmaceuticals, IncMay 21, 2015 · Mountain View, California

About this profile

What does David Eng inspect?

David Eng appears on 5 documents on file covering 5 sites, mostly in California.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.192 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for David Eng is dated May 12, 2016.

FDA Investigator David Eng: 483s & Inspections · FDA Intel